Frontlight ResearchEarly access
Liver and biliary tract cancer trials in Germany
56 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleThe ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in Intermediate-stage HepatoCellular Carcinoma
- Where
- Aachen, Amberg, Berlin, Bochum, Cologne, Dresden, Duesseldorf, Erlangen, Esslingen am Neckar, Frankfurt am Main, Frankfurt Am Main, Freiburg im Breisgau, Goettingen, Hanover, Heidelberg, Konstanz, Luebeck, Mainz, Mannheim, Marburg, Munich, Trier, Wiesbaden, Wuerzburg
- Age
- 18 years and over
- People
- 434 worldwide
- Run by
- Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
See details and how to joinNCT04803994 · EU 2024-512953-26-00 - Phase 1Taking peopleFusionVAC22_01: Fusion Transcript-based Peptide Vaccine Combined with Immune Checkpoint Inhibition
- Where
- Tuebingen, Ulm
- Age
- 18 years and over
- People
- 20
- Run by
- University Hospital Tuebingen
See details and how to joinNCT05937295 · EU 2022-502869-17-01 - Phase 2Active, not recruitingSequential or Up-front Triple Treatment With Durvalumab, Tremelimumab and Bevacizumab for Non-resectable Hepatocellular Carcinoma (HCC) Patients
- Where
- Bonn, Chemnitz, Hamburg, Mainz, Munich, Ulm, Würzburg
- Age
- 18 years and over
- People
- 83 worldwide
- Run by
- Enrico De Toni
See details and how to joinNCT05844046 · EU 2024-511439-84-00 - No phaseTaking peopleThe European NAFLD Registry
- Where
- Aachen, Berlin, Freiburg im Breisgau, Mainz, Würzburg
- Age
- 18 years to 100 years
- People
- 10,000 worldwide
- Run by
- Newcastle University
See details and how to joinNCT04442334 - No phaseTaking peopleFeasibility of Online MR-guided Radiotherapy on a 1.5T MR-Linac
- Where
- Tübingen
- Age
- 18 years and over
- People
- 472
- Run by
- University Hospital Tuebingen
See details and how to joinNCT04172753 - No phaseTaking peopleProspective Observational Trial to Evaluate Quality of Life After Stereotactic Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma
- Where
- Munich
- Age
- 18 years and over
- People
- 100
- Run by
- Ludwig-Maximilians - University of Munich
See details and how to joinNCT03253536